NYSE:BBLN - New York Stock Exchange, Inc. - JE00BQWMWC12 - Common Stock - Currency: USD
0.5504
-0.09 (-13.99%)
The current stock price of BBLN is 0.5504 USD. In the past month the price decreased by -17.84%. In the past year, price decreased by -97.82%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 36.49 | 39.24B | ||
DOCS | DOXIMITY INC-CLASS A | 47.21 | 11.34B | ||
WAY | WAYSTAR HOLDING CORP | 49.51 | 6.77B | ||
CERT | CERTARA INC | 24.78 | 1.96B | ||
SDGR | SCHRODINGER INC | N/A | 1.74B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 12.65 | 1.55B | ||
PHR | PHREESIA INC | N/A | 1.53B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.34B | ||
EVH | EVOLENT HEALTH INC - A | 24.39 | 1.09B | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 837.09M | ||
HSTM | HEALTHSTREAM INC | 43.51 | 836.83M |
Babylon Holdings Ltd. engages in the development of a mobile phone-based healthcare application. The company is headquartered in Austin, Texas and currently employs 1,895 full-time employees. The company went IPO on 2021-03-30. The firm's digital clinical platform makes information available to members so that they can monitor their health information on mobile devices, delivering digital care in countries as varied as the United States and Rwanda. The company provides 24/7 digital access to medical professionals in the United States and the United Kingdom. Its platform delivers standardized treatment protocols, administrative practices, technology, and automation, such as care for acute and chronic conditions, including chronic pain, pregnancy, cardiovascular disease, diabetes, and numerous other health concerns in a longitudinal manner. Its flagship holistic solution, Babylon 360, combines its cutting-edge technologies with human clinical expertise and provides managed care for its members across the care continuum.
BABYLON HOLDINGS LTD- CL A
2500 Bee Cave Road, Building 1 - Suite 400
Austin TEXAS US
Employees: 1895
Phone: 442071000762.0
The current stock price of BBLN is 0.5504 USD. The price decreased by -13.99% in the last trading session.
The exchange symbol of BABYLON HOLDINGS LTD- CL A is BBLN and it is listed on the New York Stock Exchange, Inc. exchange.
BBLN stock is listed on the New York Stock Exchange, Inc. exchange.
7 analysts have analysed BBLN and the average price target is 7.65 USD. This implies a price increase of 1289.9% is expected in the next year compared to the current price of 0.5504. Check the BABYLON HOLDINGS LTD- CL A stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BABYLON HOLDINGS LTD- CL A (BBLN) has a market capitalization of 14.08M USD. This makes BBLN a Nano Cap stock.
BABYLON HOLDINGS LTD- CL A (BBLN) currently has 1895 employees.
The Revenue of BABYLON HOLDINGS LTD- CL A (BBLN) is expected to grow by 11.12% in the next year. Check the estimates tab for more information on the BBLN EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BBLN does not pay a dividend.
BABYLON HOLDINGS LTD- CL A (BBLN) will report earnings on 2023-08-07, after the market close.
BABYLON HOLDINGS LTD- CL A (BBLN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-18.28).
ChartMill assigns a fundamental rating of 2 / 10 to BBLN. BBLN has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months BBLN reported a non-GAAP Earnings per Share(EPS) of -18.28. The EPS decreased by -112.81% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 40% to BBLN. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 57.13% and a revenue growth 11.12% for BBLN